pY010 (pcDNA3.1-hAsCpf1) Citations (53)
Originally described in: Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System.Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F Cell. 2015 Sep 23. pii: S0092-8674(15)01200-3. doi: 10.1016/j.cell.2015.09.038. PubMed Journal
Articles Citing pY010 (pcDNA3.1-hAsCpf1)
Showing 1 to 10 of 53 entries
Articles |
---|
Articles |
---|
Engineering of Cas12a nuclease variants with enhanced genome-editing specificity. Chen P, Zhou J, Liu H, Zhou E, He B, Wu Y, Wang H, Sun Z, Paek C, Lei J, Chen Y, Zhang X, Yin L. PLoS Biol. 2024 Mar 14;22(3):e3002514. doi: 10.1371/journal.pbio.3002514. eCollection 2024 Mar. PubMed |
Editing efficiencies with Cas9 orthologs, Cas12a endonucleases, and temperature in rice. Illa-Berenguer E, LaFayette PR, Parrott WA. Front Genome Ed. 2023 Mar 17;5:1074641. doi: 10.3389/fgeed.2023.1074641. eCollection 2023. PubMed |
The heat is on: a simple method to increase genome editing efficiency in plants. Blomme J, Develtere W, Kose A, Arraiza Ribera J, Brugmans C, Jaraba-Wallace J, Decaestecker W, Rombaut D, Baekelandt A, Daniel Fernandez Fernandez A, Van Breusegem F, Inze D, Jacobs T. BMC Plant Biol. 2022 Mar 24;22(1):142. doi: 10.1186/s12870-022-03519-7. PubMed |
A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Wang X, Dong K, Kong D, Zhou Y, Yin J, Cai F, Wang M, Ye H. Sci Adv. 2021 Dec 10;7(50):eabh2358. doi: 10.1126/sciadv.abh2358. Epub 2021 Dec 10. PubMed |
An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing. Duan N, Tang S, Zeng B, Hu Z, Hu Q, Wu L, Zhou M, Liang D. Life (Basel). 2021 Nov 18;11(11). pii: life11111262. doi: 10.3390/life11111262. PubMed |
Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles. Ageely EA, Chilamkurthy R, Jana S, Abdullahu L, O'Reilly D, Jensik PJ, Damha MJ, Gagnon KT. Nat Commun. 2021 Nov 15;12(1):6591. doi: 10.1038/s41467-021-26989-z. PubMed |
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire. Ou T, He W, Quinlan BD, Guo Y, Tran MH, Karunadharma P, Park H, Davis-Gardner ME, Yin Y, Zhang X, Wang H, Zhong G, Farzan M. Mol Ther. 2022 Jan 5;30(1):184-197. doi: 10.1016/j.ymthe.2021.10.027. Epub 2021 Nov 2. PubMed |
Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition. Zhou J, Chen P, Wang H, Liu H, Li Y, Zhang Y, Wu Y, Paek C, Sun Z, Lei J, Yin L. Mol Ther. 2022 Jan 5;30(1):244-255. doi: 10.1016/j.ymthe.2021.10.010. Epub 2021 Oct 20. PubMed |
Generation of Transgenic Rat Embryonic Stem Cells Using the CRISPR/Cpf1 System for Inducible Gene Knockout. Sherstyuk VV, Zakian SM. Biochemistry (Mosc). 2021 Jul;86(7):843-851. doi: 10.1134/S0006297921070051. PubMed |
A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020. Tran MH, Park H, Nobles CL, Karunadharma P, Pan L, Zhong G, Wang H, He W, Ou T, Crynen G, Sheptack K, Stiskin I, Mou H, Farzan M. Mol Ther Nucleic Acids. 2021 Feb 18;24:40-53. doi: 10.1016/j.omtn.2021.02.012. eCollection 2021 Jun 4. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.